Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

"Negative vaccination" by specific CD4 T cell tolerisation enhances virus-specific protective antibody responses.

Lang KS, Hegazy AN, Lang PA, Eschli B, Löhning M, Hengartner H, Zinkernagel RM, Recher M.

PLoS One. 2007 Nov 14;2(11):e1162.

2.

Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.

Oxenius A, Bachmann MF, Zinkernagel RM, Hengartner H.

Eur J Immunol. 1998 Jan;28(1):390-400.

PMID:
9485218
3.

Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells.

Battegay M, Moskophidis D, Waldner H, Bründler MA, Fung-Leung WP, Mak TW, Hengartner H, Zinkernagel RM.

J Immunol. 1993 Nov 15;151(10):5408-15. Erratum in: J Immunol 1994 Mar 1;152(5):1635.

PMID:
7693811
4.
5.

Identification of CD4+ T cell epitopes in C. burnetii antigens targeted by antibody responses.

Chen C, Dow C, Wang P, Sidney J, Read A, Harmsen A, Samuel JE, Peters B.

PLoS One. 2011 Mar 15;6(3):e17712. doi: 10.1371/journal.pone.0017712.

6.

CD4+ T-cell-epitope escape mutant virus selected in vivo.

Ciurea A, Hunziker L, Martinic MM, Oxenius A, Hengartner H, Zinkernagel RM.

Nat Med. 2001 Jul;7(7):795-800.

PMID:
11433343
8.

Chronic lymphocytic choriomeningitis virus infection actively down-regulates CD4+ T cell responses directed against a broad range of epitopes.

Mothé BR, Stewart BS, Oseroff C, Bui HH, Stogiera S, Garcia Z, Dow C, Rodriguez-Carreno MP, Kotturi M, Pasquetto V, Botten J, Crotty S, Janssen E, Buchmeier MJ, Sette A.

J Immunol. 2007 Jul 15;179(2):1058-67.

9.

Lymphocytic choriomeningitis virus infection yields overlapping CD4+ and CD8+ T-cell responses.

Dow C, Oseroff C, Peters B, Nance-Sotelo C, Sidney J, Buchmeier M, Sette A, Mothé BR.

J Virol. 2008 Dec;82(23):11734-41. doi: 10.1128/JVI.00435-08. Epub 2008 Oct 1.

10.

CD4(+) T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting.

Rodriguez F, Harkins S, Redwine JM, de Pereda JM, Whitton JL.

J Virol. 2001 Nov;75(21):10421-30.

11.

Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.

Garber DA, O'Mara LA, Zhao J, Gangadhara S, An I, Feinberg MB.

PLoS One. 2009;4(5):e5445. doi: 10.1371/journal.pone.0005445. Epub 2009 May 6.

12.

Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice.

Holst PJ, Christensen JP, Thomsen AR.

J Immunol. 2011 Apr 1;186(7):3997-4007. doi: 10.4049/jimmunol.1001251. Epub 2011 Feb 28.

15.

Rapid and sustained CD4(+) T-cell-independent immunity from adenovirus-encoded vaccine antigens.

Holst PJ, Bartholdy C, Stryhn A, Thomsen AR, Christensen JP.

J Gen Virol. 2007 Jun;88(Pt 6):1708-16.

PMID:
17485530
17.

Antiviral immune responses of mice lacking MHC class II or its associated invariant chain.

Battegay M, Bachmann MF, Burhkart C, Viville S, Benoist C, Mathis D, Hengartner H, Zinkernagel RM.

Cell Immunol. 1996 Jan 10;167(1):115-21.

PMID:
8548834
18.

Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice.

Battegay M, Moskophidis D, Rahemtulla A, Hengartner H, Mak TW, Zinkernagel RM.

J Virol. 1994 Jul;68(7):4700-4.

19.

Impairment of CD4(+) T cell responses during chronic virus infection prevents neutralizing antibody responses against virus escape mutants.

Ciurea A, Hunziker L, Klenerman P, Hengartner H, Zinkernagel RM.

J Exp Med. 2001 Feb 5;193(3):297-305.

20.

Role of T helper cell precursor frequency on vesicular stomatitis virus neutralizing antibody responses in a T cell receptor beta chain transgenic mouse.

Freer G, Burkhart C, Rülicke T, Ghelardi E, Rohrer UH, Pircher H, Zinkernagel RM, Hengartner H.

Eur J Immunol. 1995 May;25(5):1410-6.

PMID:
7539759

Supplemental Content

Support Center